CXCL5 and renal cell carcinoma: Next, we evaluated the chemotactic effects of recombinant human CXCL5 on RCC cells (Fig. 5C), suggesting a significant increase in RCCs cell migration after treatment with 40 ng/mL of exogenous CXCL5 (Fig. 5D).